PIA
VNDA icon

Piedmont Investment Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Piedmont Investment Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,198
Closed -$243K – 1264
2019
Q1 		$243K Buy
13,198
+737
+6% +$16.8K 0.01% 953
2018
Q4 		$326K Buy
12,461
+372
+3% +$8.75K 0.02% 668
2018
Q3 		$277K Buy
12,089
+11,197
+1,255% +$229K 0.01% 818
2018
Q2 		$17K Buy
+892
New +$14.9K ﹤0.01% 1641

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Piedmont Investment Advisors's VNDA Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Vanda Pharmaceuticals (VNDA) in Q2 2019, closing a stake of 13,198 shares — an estimated $243K sold.

Piedmont Investment Advisors first reported a position in VNDA in Q2 2018 and held it in 4 quarters. The position peaked at $326K in Q4 2018. 164 funds tracked by Wall St. Rank hold VNDA as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining Vanda Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 13,198 Vanda Pharmaceuticals shares in Q2 2019, an estimated $243K.
  • Piedmont Investment Advisors first reported a position in Vanda Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Piedmont Investment Advisors's Vanda Pharmaceuticals position peaked at $326K in Q4 2018.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.